SPOP and posterior cortical atrophy: SPOP mutations and ETS fusions are mutually exclusive, and studies have identified molecular subtypes of PCa based on the genetic driver present; however, these genetic events have not conferred any prognostic or predictive information to date, nor could they be used to guide therapy selection.